Lisata Therapeutics
LSTA
LSTA
29 hedge funds and large institutions have $4.49M invested in Lisata Therapeutics in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
99% less call options, than puts
Call options by funds: $1K | Put options by funds: $77K
Holders
29
Holding in Top 10
–
Calls
$1K
Puts
$77K
Top Buyers
| 1 | +$497K | |
| 2 | +$287K | |
| 3 | +$68K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$33.7K |
| 5 |
Morgan Stanley
New York
|
+$25K |
Top Sellers
| 1 | -$226K | |
| 2 | -$72.4K | |
| 3 | -$18.5K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$6.86K |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$3.3K |